Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Dehydrocrenatidine |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
Dehydrocrenatidine is a selective JAK2 inhibitor, which decreases STAT3 signaling to prevent cell proliferation (PMID: 25583084). |
| DrugClasses | JAK2 Inhibitor 19 |
| CAS Registry Number | 65236-62-6 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Dehydrocrenatidine | Dehydrocrenatidine | 0 | 0 |